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The effect of insoluble glucan synthesized by Streptococcus mutans on [3H]arachidonate metabolites 
secretion from peritoneal macrophages was studied. Insoluble glucans timulated [3H]arachidonate release 
and secretion of prostaglandin E2 and thromboxane B2 from macrophages. In contrast, commercial 
soluble glucan (dextran) did not induce [‘Hlarachidonate r lease. 
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1. INTRODUCTION 
Dental plaque microorganisms and their 
metabolic products such as toxins, enzymes and 
polysaccharides have been shown to induce 
gingivitis and periodontitis [ 11. Bacterial polysac- 
charides are known to be present in significant 
quantities in dental plaque [2]. A prime determi- 
nant of the ability of S. mutans to form dental pla- 
que is the capacity of the organism to synthesize 
high M, glucans from sucrose, including highly 
branched polymer glucans that have a-1,6 and 
o- 1,3-glucosidic linkages [3]. Ivanyi has reported 
that branched dextran from dental plaque is, addi- 
tionally, a B-cell mitogen for human lymphocytes 
and that the incidence and magnitude of the 
response to branched dextran increased in patients 
with gingival periodontal disease when compared 
to subjects with clinically healthy gingiva [4]. 
Arachidonic acid metabolites appear to be involv- 
ed in the regulation of inflammation [5]. PGEz has 
been detected in human gingival tissue with 
periodontal diseases [6], and PG-like products 
have been detected in the culture media of gingival 
culture [7]. Administration of PGE2 in organ 
culture [8] or in vivo [9] induces bone resorption. 
The presence in periodontal disease gingiva of in- 
creased levels of TXBz may reflect the accumula- 
tion of inflammatory cells within the gingiva [lo]. 
TXB2 is the stable end product of TXA2, which has 
been shown to possess potent vascular smooth 
muscle contraction activity [I l] and to induce ir- 
reversible platelet aggregation [12]. It is known 
that macrophages have a key role in mediating in- 
flammatory reactions [ 131 and macrophages are a 
presumable source of PGEz and TXBz release [141. 
Here we present evidence that insoluble glucans 
obtained from S. mutans induce PGE2 and TXB2 
secretion from macrophages in cell culture. 
Abbreviations: S. mutans, Streptococcus mutans, 
PGE2, prostaglandin E2, TXB2, thromboxane B2, AA, 
arachidonic acid 
2. MATERIALS AND METHODS 
2.1. Macrophage culture 
Peritoneal exudate cells were induced by the in- 
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jection of sterile 0.1% glycogen (0.30 pm filter) 
into female guinea pigs. After 3 days, animals were 
anesthesized with ether, rapidly bled from the 
heart and perfused with saline solution. Then, 
peritoneal exudate cells were harvested with RPM1 
1640 medium containing 5 mM Tris-HCl (pH 7.4), 
100 units/ml penicillin G, 100 pg/ml streptomycin 
sulfate and 0.38% sodium citrate. When red blood 
cells were present, these were lysed with hypotonic 
saline (0.2%) for 30 s and diluted with an equal 
volume of 1.6% NaCl solution. The cells were 
washed twice with RPM1 1640 medium without 
sodium citrate and plated at 1 x lo6 cells/well 
(Linbro tissue culture multi-well plate, 2.0 cm2). 
After incubation for 2 h at 37°C in 5% CO2 in air, 
the non-adherent cells were washed off twice. 
2.2. S. mutans glucans 
Insoluble glucans from various species of S. 
mutans were prepared as in [15]. Estimation of 
a-1,3 glucosidic linkage contents in glucans was 
carried out by measuring the hydrolysis with excess 
dextranase. The reaction mixture contained 
100 mM sodium acetate buffer (pH 6.0), 2 units 
dextranase (from Penicillium sp., Sigma Chemical 
Co.) and 1 mg glucan. Hydrolysis of glucan was 
carried out at 37°C for 24 h. The hydrolyzed 
sugars were determined by phenol-sulfuric acid 
reaction. The suspended insoluble glucans were 
sterilized in the autoclave. Aggregated insoluble 
glucans were resuspended by sonication and 
diluted with RPM1 medium for use. 
2.3. Assay for [3H]arachidonate release 
Fresh RPM1 1640 medium (0.5 ml) containing 
0.1% bovine serum albumin (BSA) and 0.15 ,&i 
[5,6,8,9,11,12,14,15-3H] arachidonic acid; 127 
Ci/mmol (Amersham) was added to adherent 
macrophage cells in the tissue culture multi-well 
plate. After 16 h incubation, the radiolabeled 
macrophages were washed twice with Hank’s 
balanced salt solution; and fresh medium contain- 
ing 0.1 Vo BSA with or without glucans was added. 
The radioactivity released into the medium was 
determined after incubation for varying times. 
2.4. Chromatography of 13H]PGE2 and ~H]TX& 
Radioactive products in the medium were ex- 
tracted and determined as in [ 161. As standards, 
360 nmol PGEz and TXB2 were also mixed with 
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Table 1. 
Effect of various insoluble glucans on arachidonate 
release 
Inducer 
added 
[3H]arachidonate 
released (dpm) 
Relative 
activity 
Controls 
None 9562k 31.5 1.00 
Dextran 9258 f 941 0.97 
Insoluble glucans from 
S. mutans train (serotype) 
6715 (gl 25986 + 1876a 2.72 
OMZ-176 W 13746 f 2330b 1.44 
PS-14 0 11425 _+ 982b 1.20 
QP-50 (c) 10652 f 660b 1.11 
aPfO.OO1, bP<0.05 compared with zero. 
Macrophage culture (1.0 x lo6 cells/well) were 
prelabeled with [‘Hlarachidonic acid for 16 h. The cells 
were incubated with or without each inducer for 4 h at 
37°C in 5% COz in air. The concentrations of insoluble 
glucans and dextran were 500ag/ml. All results are 
expressed as the mean + SD (n = 4) 
2 4 6 6 
Incubation time (hr) 
Fig. 1. Time-dependent release of [3H]arachidonate. 
Macrophage cultures (1 x lo6 cells/well) were prelabeled 
with [3H]arachidonic acid for 16 h. The cells were 
incubated with insoluble glucan obtained from S. 
mutans 6715 (-&- 250 ,ug/ml) or without (h). 
Results show the mean k SEM of 4 different exp. 
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Table 2 
t3H~arachidonate metabolites elicited by insolubie glucan 
Incubation time Insoluble glucan 
added (6715) 
4h None 
500 pg/mI 
8h None 
500 pg/ml 
“P<O.Ol compared with none 
PGEz 
3H-released Rel. act. (olo) 
(dpm) 
33 f 15 100.0 
359* 52 1087.8’ 
116+ 16 100.0 
1257 + 199 1083.6a 
TXB2 
3H-released Relative activity 
(dpm) (Q) 
67% 8 100.0 
938 t- 200 1400.0a 
136+ 18 100.0 
1506 f 303 1 107.4a 
13H]Arachidonate m tabolites released from macrophages after addition of 0.5 ml RPM1 1640 medium containing 
500 pg/mI insoluble glucan suspension were extracted and chromatographed on silical-gel G plates, using the solvent 
system described in the text. Spots of chromatographed authentic samples were detected by iodine vapor and 
radioactivity in the areas was counted. The values are expressed as mean + SD (n = 4). 
the extracts. The plates (silica gel-G) were 
developed with a solvent system [benzene: 1,4- 
dioxane: acetic acid (60: 30: l)] chosen to separate 
PGE:! and TXBz and then visualized by exposure 
to iodine vapor. The areas corresponding to 
authentic PGE2 and TXB;! on the chromatograms 
were cut out and the radioactivity was determined 
using a liquid scintillation counter. 
3. RESULTS 
We have found that the percentage solubiliza- 
tion of glucans differed between various S. 
mutans; 6715 (ll%), QP-50 (36Yo), OMZ-176 
(58%) and PS-14 (68%); suggesting that glucan 
from S. mutans 6715 has the highest amount of 
a-1,3 glucosidic linkage content. The effect of in- 
soluble glucans synthesized by several strains of S. 
mutans on t3H]AA release from macrophages was 
examined. About 55% of i3H]AA radioactivity 
added was incorporated into macrophages and 
70010 of the incorporated radioactivity was 
distributed into the phospholipid fraction under 
our incubation conditions (not shown). Insoluble 
glucan from S. mutans strain 6715 caused the 
highest [‘H]AA release, whereas commercial solu- 
ble dextran (iW 5-40 x 106) did not induce 
[3H]AA release. The 13H]AA release stimulated by 
various concentrations of insoluble glucan from S. 
mutans 67 15 occurred in a time-dependent manner 
over 8 h (Fig. 1). The [3H]AA metabolites released 
in culture medium by stimulation with 5OO~tg/mI 
insoluble glucan from S. mutans 6715 were iden- 
tified by thin-layer chromatography. At 500 pg/ml, 
insoluble glucan from S. mutans 6715 caused an 
11-fold increase in secretion of [3H]PGE2 and a 
1Cfold increase in t3H]TXB2 secretion at 4 h and 
an 1 l-fold increase in secretion of both [3H]PGE2 
and 13H]TXBz at 8 h as shown in table 2. 
4. DISCUSSION 
This study demonstrates that insoluble glucan 
from S. mutuns can dramatically induce glycogen- 
elicited guinea pig peritoneal macrophages to 
secrete PGEt and TXB2. The magnitude of 
response is dependent on the duration of incuba- 
tion time. 
Considerable evidence has accumulated regard- 
ing the chemical structure of insoluble glucans 
from various strains of S. mutans. The large pro- 
portion of tu-1,3-glucosidic linkages found in in- 
soluble glucan explains the insoluble nature of this 
poIymer and the consecutive cr-1,3-glucosidic 
linkages from long chains as the backbone of a 
highly branched insoluble glucan [3]. Since mor- 
phology and size of insoluble glucan from S. 
mutans has the fibrillar form (28 x 5.2 nm) [ 171, 
and sonicated insoluble glucan has a high M, 
(> 1.5 x 10’) [18], macrophage phagocytosis of in- 
soluble glucan might be related to their [3H]AA 
metabolism. 
Several serotypes of S. muta~ may be responsi- 
ble for dental plaque formation, but it is not clear 
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whether one serotype is more virulent than 
another. We have found that glucan from S. 
mutans 6715 had the highest a-1,3 glucosidic 
linkage content. When compared with our data in 
table 1, insoluble glucans from S. mutans 6715 
caused the highest [3H]AA release, it suggests that 
[3H]AA release from macrophages may depend on 
the proportion of a-l,3 glucosidic linkage contents 
of glucan. We have not investigated here the func- 
tional mechanisms of al,3 glucosidec linkage 
glucan on the stimulation of AA release. In [19], 
alveolar macrophage phagocytosis of zymosan in- 
creased the release of AA and PGs; in contrast, 
phagocytosis of inert latex particles had no effect 
[ 191. The insoluble polysaccharide p-1,3 glucan is 
the active component of zymosan for producing 
hyperplasia and hyperfunction of the reticulo- 
endothelial system [20]. The following possibilities 
may therefore be considered: membrane changes 
occurring after interiorization of the cell surface by 
phagocytosis of a-1,3 glucosidic linkage glucan 
may play roles of Ca2+ efflux, activation of mem- 
brane phospholipase A2 or C, or release of 
lysosomal phospholipase A2 related to AA release. 
TXB2 and PGEz may contribute to inflam- 
matory processes by causing chemotaxis of 
leukocytes, vascular permeability and histamine 
release [21,22]. Prior treatment of rat gingival 
epithelial surface with Streptococcus hyaluronid- 
ase allowed penetration of the polysaccharide 
resulting in destructive changes in rat gingiva [23]. 
Thus, our data suggest that insoluble glucan 
from S. mutans in dental plaque may contribute to 
pathophysiological inflammation and bone resorp- 
tion in periodontal tissues through the induction of 
TXBz and PGEz release from macrophages. Ex- 
periments to clarify the detailed mechanism of 
a-1,3 glucosidic linkage insoluble glucan on AA 
release from macrophages are in progress. 
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